Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin

Human Molecular Genetics

Volumn 11, Issue 9, 2002, Pages 1137-1151

  Wyttenbach, Andreas ^a   Sauvageot, Olivier ^b   Carmichael, Jenny ^a   Diaz Latoud, Chantal ^b   Arrigo, Andre Patrik ^b   Rubinsztein, David C ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CHAPERONE; CYTOCHROME C; GLUTATHIONE; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HUNTINGTIN; POLYGLUTAMINE; REACTIVE OXYGEN METABOLITE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL DEATH; CELL PROTECTION; CELL STRAIN COS7; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE MODEL; ENZYME RELEASE; GENE MUTATION; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; HYPOTHESIS; INHIBITION KINETICS; MITOCHONDRION; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALIA;

EID: 0036566675     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.9.1137     Document Type: Article

References (57)

1. Intranuclear neuronal inclusions: A common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?
2. Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease
3. Glutamine repeats and neurodegenerative diseases: Molecular aspects
4. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
5. Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases
6. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapy
7. Genetic suppression of polyglutamine toxicity in Drosophila
8. Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening
9. Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils
10. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
11. Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease
12. Polyglutamine length-dependent interaction of hsp40 and hsp70 family chaperones with truncated N-terminal huntingtin: Their role in suppression of aggregation and cellular toxicity
13. Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract
14. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone
15. Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease
16. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70
17. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans
18. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice
19. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease
20. A role for heat shock protein 27 in CTL-mediated cell death
21. Hsp27 negatively regulates cell death by interacting with cytochrome c
22. Negative regulation of the Apaf-1 apoptosome by Hsp70
23. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome
24. Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3
25. Hsp72-mediated suppression of c-Jun N-terminal kinase is implicated in development of tolerance to caspase-independent cell death
26. The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells
27. Inhibition of Daxx-mediated apoptosis by heat shock protein 27
28. A role for HSP27 in sensory neuron survival
29. Protection of neuronal cells from apoptosis by Hsp27 delivered with a herpes simplex virus-based vector
30. Large unphosphorylated aggregates as the active form of hsp27 which controls intracellular reactive oxygen species and glutathione levels and generates a protection against TNFalpha in NIH-3T3-ras cells
31. Regulation of HSP27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor α by phospohrylation
32. Intranuclear huntingtin increases the expression of caspase-1 and induces apoptosis
33. The biochemistry of apoptosis
34. TNF-alpha signals apoptosis through a Bid-dependent conformational change in Bax that is inhibited by E1B 19K
35. Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins
36. 3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways
37. Cyclic AMP-induced neuronal differentiation via activation of p38 mitogen-activated protein kinase
38. Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2
39. A molecular investigation of true dominance in Huntington's disease
40. N-acetylcysteine (D-and L-stereoisomers) prevents apoptotic death of neuronal cells
41. Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila
42. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
43. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy
44. Chaperone suppression of cellular toxicity of huntingtin is independent of polyglutamine aggregation
45. Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse
46. Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex
47. Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin
48. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease
49. Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery
50. Proteasome inhibition in oxidative stress neurotoxicity: Implications for heat shock proteins
51. Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production
52. Impairment of the ubiquitin-proteasome system by protein aggregation
53. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization
54. The role of mitochondria in the pathogenesis of neurodegenerative diseases
55. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization
56. Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death
57. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species